2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children-Reference-Cited by-同舟云学术

2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children

Published:2018-03-14 Issue:4 Volume:12 Page:423-437
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Kissling Esther¹^ORCID,Valenciano Marta¹,Pozo Francisco²,Vilcu Ana-Maria³,Reuss Annicka⁴,Rizzo Caterina⁵,Larrauri Amparo⁶⁷^ORCID,Horváth Judit Krisztina⁸,Brytting Mia⁹,Domegan Lisa¹⁰,Korczyńska Monika¹¹,Meijer Adam¹²,Machado Ausenda¹³^ORCID,Ivanciuc Alina¹⁴,Višekruna Vučina Vesna¹⁵,van der Werf Sylvie¹⁶,Schweiger Brunhilde¹⁷,Bella Antonino⁵,Gherasim Alin⁶,Ferenczi Annamária⁸,Zakikhany Katherina⁹,O′Donnell Joan¹⁰,Paradowska-Stankiewicz Iwona¹¹,Dijkstra Frederika¹²,Guiomar Raquel¹³,Lazar Mihaela¹⁴,Kurečić Filipović Sanja¹⁵,Johansen Kari¹⁸,Moren Alain¹,

Affiliation:

1. EpiConcept; Paris France

2. National Centre for Microbiology; Instituto de Salud Carlos III; Madrid Spain

3. Sorbonne Universités; UPMC Univ Paris 06; INSERM; Institut Pierre Louis d’épidémiologie et de Santé Publique (IPLESP UMRS 1136); Paris France

4. Department for Infectious Disease Epidemiology; Robert Koch Institute; Berlin Germany

5. Department of Infectious Disease; Istituto Superiore di Sanità; Rome Italy

6. National Centre for Epidemiology; Instituto de Salud Carlos III; Madrid Spain

7. Ciber Epidemiología y Salud Pública (CIBERESP); Madrid Spain

8. National Centre for Epidemiology; Budapest Hungary

9. The Public Health Agency of Sweden; Stockholm Sweden

10. Health Service Executive - Health Protection Surveillance Centre; Dublin Ireland

11. National Institute of Public Health-National Institute of Hygiene; Warsaw Poland

12. Centre for Infectious Disease Control; National Institute for Public Health and the Environment; Bilthoven The Netherlands

13. Instituto Nacional de Saúde; Dr Ricardo Jorge; Lisbon Portugal

14. Development for Microbiology and Immunology; Cantacuzino Institute; National Institute of Research; Bucharest Romania

15. Croatian Institute of Public Health; Zagreb Croatia

16. Institut Pasteur; Paris France

17. National Reference Centre for Influenza; Robert Koch Institute; Berlin Germany

18. European Centre for Disease Prevention and Control (ECDC); Stockholm Sweden

Funder

Horizon 2020 Framework Programme

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/irv.12520/fullpdf

Reference28 articles.

1. Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study;Kissling;Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull,2016

2. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study;Kissling;Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull,2013

3. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13;Kissling;Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull,2014

4. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2);Valenciano;Vaccine,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study;Influenza and Other Respiratory Viruses;2024-01

2. Impact of Influenza Vaccination on the Burden of Severe Influenza in the Elderly: Spain, 2017–2020;Vaccines;2023-06-17

3. Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis;The Lancet Respiratory Medicine;2023-01

4. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study;Influenza and Other Respiratory Viruses;2022-11-21

5. Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population;Vaccines;2022-08-09